Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
colorectal cancer
Biotech
Roche's R&D rethink hits 20% of molecules as cancer drugs axed
The culls are part of a broader refocusing that has removed 20% of new molecules from the pipeline in recent quarters.
Nick Paul Taylor
Apr 24, 2024 4:27am
Daily aspirin use may limit spread of colorectal tumor cells
Apr 23, 2024 3:50am
BMS-backed TORL grabs $158M to march army of ADCs through clinic
Apr 10, 2024 9:35am
Gritstone ground down by phase 2 cancer vaccine fail
Apr 2, 2024 5:09am
Epigenetic cancer drug duo packs punch against colorectal cancer
Apr 1, 2024 3:20pm
Mouth microbe on the move may drive colorectal cancer
Mar 25, 2024 3:30pm